Spectrawave
Bedford, US · Founded 2017 · Delaware corporation · 24 employees on LinkedIn · 5 known investors
Find your way into Spectrawave
475 people in our graph share verified history with the Spectrawave team — schools, employers, funds. One of them is your warm intro.
Anthony Philippakisunlockedknows Eman Namati · together at Harvard Medical School (overlapped)
×2knows the team · via Harvard Medical School
×5knows the team · via Massachusetts General Hospital
knows the team · via Johnson & Johnson MedTech
knows the team · via NinePoint Medical
×2knows the team · via The University of Kansas
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
Founders & leadership
Spectrawave was founded in 2017 by Eman Namati, Guillermo Tearney, Gregg Stone, James Muller, and Jeffrey O'Donnell.
EN
Eman NamatiinCo-founder · President, CEO, and Board Director2020–2026Eman Namati served as President & CEO of SpectraWAVE, where he led development of intravascular imaging and AI-enabled physiology technologies before the company's acquisition by Philips. Over two decades, he has held leadership roles in venture-backed medical device companies through product development, FDA clearance, and commercialization phases, and currently leads advanced imaging initiatives at Philips.
GT
Guillermo TearneyFounder; Professor of Pathology, Massachusetts General Hospital
GS
Gregg StoneFounder; Professor of Medicine, Mount Sinai Heart Health System
JM
James MullerinFounder; Cardiologist, Brigham and Women's HospitalJames Muller is a cardiologist who held faculty positions at Harvard Medical School and Brigham and Women's Hospital and has over four decades of clinical and research experience in cardiology. He co-founded SpectraWAVE and previously co-founded InfraReDx, developing imaging technologies for coronary artery disease diagnosis and treatment.
JO
Jeffrey O'DonnellFounder; Managing General Partner, Runway Healthcare
VW
Vivek WalimbeinChief Operating OfficerVivek Walimbe holds a PhD in Biomedical Engineering from Ohio State University and brings over 20 years of medical device experience across GE Healthcare, Medtronic, Baxter, and J&J MedTech, with roles spanning R&D leadership, product development, and regulatory affairs in imaging, therapy platforms, and AI-driven clinical solutions. At SpectraWAVE, he served as COO overseeing product development and commercialization before the company's acquisition by Philips.
BD
Brad DavisinChief Commercial OfficerBrad Davis is Chief Commercial Officer of SpectraWAVE, which develops optical and computational imaging technologies for coronary artery and cardiovascular disease diagnosis. He brings over 25 years of medical device commercialization experience, including prior roles as first Chief Commercial Officer at OpSens Medical (which exited to Haemonetics) and senior commercial positions at Cardiovascular Systems, where he contributed to a $890 million acquisition by Abbott.
BK
Bill KellyinChief Financial Officer
JH
Jonathan HillinChief Medical Officer
ES
Eric SwansonNamed on SEC filing
MS
Martin SeifertNamed on SEC filing
Board
PL
Investors · 5
Reported raises · per SEC filings
Form D private placements$66.7M disclosed across 2 rounds · 2019–2024
▶$50.3MraisedOct 2024 · 33 investors · OtherRule 506(b)
▶$50.3MraisedOct 2024 · 33 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eman NamatiExecutive Officer, Director
- Paul LaVioletteDirector
- Gerry BrunkDirector
- Bill LittleDirector
- David NeustaedterDirector
- Brian SmithDirector
- Kadir KadhiresanDirector
- Offering amount
- $50.3M
- Amount sold
- $50.3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.4MraisedMay 2019 · 19 investors · OtherRule 506(b)
▶$16.4MraisedMay 2019 · 19 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric SwansonDirector
- Martin SeifertExecutive Officer, Director
- Steven HochbergDirector
- Guillermo TearneyDirector
- Offering amount
- $16.4M
- Amount sold
- $16.4M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Spectrawave went on to found or lead other companies.
Competitors · 5
by search overlap
Boston Scientific10 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Cqmedical9 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Itnonline9 shared keywordsImaging Technology News is a trade publication that reaches over 34,000 radiology, radiation oncology, women's health, and nuclear medicine professionals with editorial content and product comparison tools. The publication serves as a primary resource for healthcare technology purchasing decisions within medical imaging specialties.
Sonavex8 shared keywordsSonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.
Rf Surgical7 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Spectrawave for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Spectrawave do?
- SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
- Who founded Spectrawave?
- Spectrawave was founded by Eman Namati, Guillermo Tearney, Gregg Stone, James Muller, Jeffrey O'Donnell in 2017.
- Who are Spectrawave's investors?
- Spectrawave's investors include Lumira Ventures, S3 Ventures, SV Health Investors, Deerfield Management Company, Johnson & Johnson Innovation – JJDC.
- How much funding has Spectrawave raised?
- Spectrawave has disclosed $66.7M raised across 2 rounds.
- Where is Spectrawave headquartered?
- Spectrawave is headquartered in Bedford, US.